Plante Moran Financial Advisors, LLC Biogen Inc. Transaction History
Plante Moran Financial Advisors, LLC
- $1.2 Billion
- Q4 2024
A detailed history of Plante Moran Financial Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Plante Moran Financial Advisors, LLC holds 17 shares of BIIB stock, worth $2,021. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17
Previous 37
54.05%
Holding current value
$2,021
Previous $7,000
71.43%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding BIIB
# of Institutions
1,017Shares Held
127MCall Options Held
1.77MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA16.7MShares$1.99 Billion0.05% of portfolio
-
Primecap Management CO Pasadena, CA16MShares$1.91 Billion1.94% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.73 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$880 Million0.05% of portfolio
-
Geode Capital Management, LLC Boston, MA3.7MShares$439 Million0.04% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $17.1B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...